The novel virus SARS-CoV-2 and the resulting disease COVID-19 are currently of great importance. We are all more or less affected, both professionally and privately. In this situation regarding COVID-19 pandemic it is of great importance to detect active or recent infections with SARS-CoV-2 virus.

MEDsan® GmbH provides different in vitro diagnostics for the detection of SARS-CoV-2 nucleic acids as well as the specific IgM and IgG antibodies against SARS-CoV-2 infected cells. 

MEDsan® COVID-19 IgM/IgG Rapid Test

  • relative Sensitivity (IgG): 98.3% ; relative Sensitivity (IgM): 87.6%
  • relative Specificity (IgG): 99.7%; relative Specificity (IgM): 99.9%
The global pandemic caused by the virus known as SARS-CoV-2 affects us all. Human uncertainty is particularly great these days. This makes it all the more important to be able to offer a good, uncomplicated test method that can be used to get the right indication for makeing the right decisions. MEDsan® COVID-19 IgM/IgG Rapid Test is a solid phase immunochromatographic assay for the rapid, qualitative and differential detection of IgM and IgG antibodies against novel coronavirus SARS-CoV-2 infected cells in human whole blood, serum or plasma. The test kit is for professional use only and provides results within 10-15 minutes. With this rapid test for the detection of antibodies in the blood of patients, you can now quickly and easily check what your status is for a COVID-19 disease. You will have feedback on the status within a very short time. You will find more informaton after registration in our expert group.

BioeXsen SARS-CoV-2 RT PCR

Sensitivity: 98.7% Specificity: >99.9%

  • Sample to result in 1 hour: No need for nucleic acid extraction; fast thermal cycling
  • 94 clinical samples in 1 hour in 96 well-plate qPCR instrument
  • Required detection channels: FAM, HEX
  • Avaliable as 100, 250 and 1000 reactions.


You will find more informaton after registration in our expert group.

MEDsan® Urine Test Marijuana (THC) test is a competitive immunoassay utilizing highly specific reactions between antibodies and antigens for the qualitative determination of cannabinoids in human urine.

The test is the first step in a two-step process to provide consumers with information concerning the presence or absence of the above stated drug in a urine sample.

Information regarding confirmatory testing along with the materials for shipping a portion of the urine specimen to the laboratory for confirmation testing of a preliminary positive result is provided.

GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

  • Qualitative results within 5 minutes.
  • High sensitivity and specificity.
  • Results are easy to read and require no additional instrumentation or reagents.

The package insert is currently available in 8 languages (German, English, Spanish, French, Italian, Portugues, Polish, Russian). Further languages are available upon request within 2 days.

Our leading expert team of chemists, biologists, pharmacists and medical doctors are available for our exclusive partners.

GDPR Cookie Consent with Real Cookie Banner